CFDE Data Portal | Search LRRC55

	Label	Description
	LRRC55 associations Collection (Entity type)	Associations for LRRC55_associations
	LRRC55 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LRRC55 Gene (Entity type)	ENSG00000183908 - leucine rich repeat containing 55
	LRRC55 IDG ionchannel ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE139987 1 V 0 ROSIGLITAZONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE139987 1 V 2 ROSIGLITAZONE MOUSE DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 10 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 0 V 1 DOXORUBICIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE216273,GSE216292 14 V 1 PALBOCICLIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

LRRC55 associations

Associations for LRRC55_associations

LRRC55 associations.tsv

A file from IDG as part of the Harmonizome project

LRRC55

ENSG00000183908 - leucine rich repeat containing 55

LRRC55 IDG ionchannel ARCHS4 coexpression

A Gene Set from IDG

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE139987 1 V 0 ROSIGLITAZONE MOUSE DN

A Gene Set from LINCS

GSE139987 1 V 2 ROSIGLITAZONE MOUSE DN

A Gene Set from LINCS

GSE100148 EZH2 inhibition 10 v 5 human dn

A Gene Set from LINCS

GSE181517 0 V 1 DOXORUBICIN HUMAN DN

A Gene Set from LINCS

GSE216273,GSE216292 14 V 1 PALBOCICLIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.